Molecular structure of human histocompatibility antigens: the HLA‐C series
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The HLA‐CW2 antigen of the B lymphoblastoid cell line BRI 8 is structurally homologous to the HLA‐A and B antigens as judged by various criteria. Each antigen comprised a glycosylated polypeptide of 43 000 molecular weight that is noncovalently associated with β 2–microglobulin (β 2 m). Some small differences in molecular parameters were, however, revealed. Thus, the deoxycholate‐solubilized HLA‐CW2 antigen sedimented at the same rate as the HLA‐A antigens but at a slightly faster rate than the HLA‐B antigens. This variation is apparently due to different amounts of bound deoxy‐cholate. Also, whereas essentially all of the HLA‐A and B antigens and about half of the HLA‐CW2 antigen were adsorbed Strongly by Lens culinaris lectin‐Sepharose, the remaining HLA‐CW2 antigen was bound much more weakly and did not require sugar for elution. This difference reflects some structural heterogeneity in the carbohydrate moiety of the HLA‐CW2 antigen. The results of various studies suggest that the HLA‐CW2 antigen is expressed to a lower extent than the HLA‐A or B antigens and that essentially all of the β 2 m of the BRI 8 plasma membrane is associated with the HLA‐A, B and C alloantigenic polypeptides.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Our findings may be explained because HLA-B is generally expressed at higher levels on the cell surface than HLA-A and HLA-C and because HLA-B alleles bind to a greater diversity of peptides (38, 39).”
From Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy (2018) · cites this paper as [38]
Citations
Cites
Braun, W. E., Grecek, D. R., & Murphy, J. J. (1971) · Surgical Clinics of North America · doi:10.1016/s0039-6109(16)39542-1 · Cited by 1,897
HISTOCOMPATIBILITY TESTING, 1972
(1974) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1974.tb70792.x · Cited by 1,178
Histocompatibility Testing, 1975
Taylor, G. M. (1976) · British Journal of Cancer · doi:10.1038/bjc.1976.129 · Cited by 778
Hayman, M. J., & Crumpton, M. J. (1972) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(72)90581-5 · Cited by 346
Self-citationThe β2-microglobulin gene is on chromosome 15 and not in the HL-A region
GOODFELLOW, P. N., JONES, E. A., VAN HEYNINGEN, V., SOLOMON, E., BOBROW, M., MIGGIANO, V., & BODMER, W. F. (1975) · Nature · doi:10.1038/254267a0 · Cited by 272
Self-citationEffect of dimethylnitrosamine on persistence of methylated guanines in rat liver and kidney DNA
NICOLL, J. W., SWANN, P. F., & PEGG, A. E. (1975) · Nature · doi:10.1038/254261a0 · Cited by 184
Chemical characterisation of the Thy-1 glycoproteins from the membranes of rat thymocytes and brain
Neil Barclay, A., Letarte-Muirhead, M., Williams, A. F., & Faulkes, R. A. (1976) · Nature · doi:10.1038/263563a0 · Cited by 182
EXPRESSION OF HLA SYSTEM ANTIGENS ON PLACENTA
Goodfellow, P. N., Barnstable, C. J., Bodmer, W. F., Snary, D., & Crumpton, M. J. (1976) · Transplantation · doi:10.1097/00007890-197612000-00009 · Cited by 180
Self-citationPapain-Solubilized HL-A Antigens from Cultured Human Lymphocytes Contain Two Peptide Fragments
Cresswell, P., Turner, M. J., & Strominger, J. L. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.5.1603 · Cited by 164
Terhorst, C., Parham, P., Mann, D. L., & Strominger, J. L. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.3.910 · Cited by 162
Research works printed but not linked: 9
- Möller G., 1974, Transplant. Rev., 21
- Tanigaki N., 1974, Immunology, 26, 155
- Arce‐Gomez B. Jones E.A. Barnstable C.J. Solomon E.andBodmer W.F. Tissue Antigens1977 in press.
- Mayr W.R., 1973, Transplant. Proc., 5, 1581
- Dausset J., 1973, Histocompatibility Testing 1972
- Bodmer W.F., 1973, Manual of Tissue Typing Techniques, 74
- Nakamuro K., 1977, Immunology, 32, 139
- Snary D., 1977, Proc Cell Culture Conf., and Birmingham, A.a.
- Bodmer W.F., 1973, Transplant Proc., 5, 1471
Cited by
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Havel, J. J., Chowell, D., & Chan, T. A. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0116-x · Cited by 2,286
Barnstable, C. (1978) · Cell · doi:10.1016/0092-8674(78)90296-9 · Cited by 1,916
Self-citationPatient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
Chowell, D., Morris, L. G. T., Grigg, C. M., Weber, J. K., Samstein, R. M., Makarov, V., Kuo, F., Kendall, S. M., Requena, D., Riaz, N., et al. (2018) · Science · doi:10.1126/science.aao4572 · Cited by 1,142
KIR: Diverse, Rapidly Evolving Receptors of Innate and Adaptive Immunity
Vilches, C., & Parham, P. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.092501.134942 · Cited by 986
Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA
Kiepiela, P., Leslie, A. J., Honeyborne, I., Ramduth, D., Thobakgale, C., Chetty, S., Rathnavalu, P., Moore, C., Pfafferott, K. J., Hilton, L., et al. (2004) · Nature · doi:10.1038/nature03113 · Cited by 842
“HLA-C alleles are expressed at lower levels on the cell surface than HLA-A and HLA-B (ref”
BackgroundMonoclonal Antibodies for Analysis of the HLA System
Brodsky, F. M., Parham, P., Barnstable, C. J., Crumpton, M. J., & BOdmer, W. F. (1979) · Immunological Reviews · doi:10.1111/j.1600-065x.1979.tb00288.x · Cited by 733
Self-citationPathogen-Driven Selection and Worldwide HLA Class I Diversity
Prugnolle, F., Manica, A., Charpentier, M., Guégan, J. F., Guernier, V., & Balloux, F. (2005) · Current Biology · doi:10.1016/j.cub.2005.04.050 · Cited by 506
“cell surface than HLA A and HLA B [ 31 ], and, thus, it is”
BackgroundColonna, M., Borsellino, G., Falco, M., Ferrara, G. B., & Strominger, J. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.12000 · Cited by 460
Differential microRNA regulation of HLA-C expression and its association with HIV control
Kulkarni, S., Savan, R., Qi, Y., Gao, X., Yuki, Y., Bass, S. E., Martin, M. P., Hunt, P., Deeks, S. G., Telenti, A., et al. (2011) · Nature · doi:10.1038/nature09914 · Cited by 326
Brodsky, F. M., Bodmer, W. F., & Parham, P. (1979) · European Journal of Immunology · doi:10.1002/eji.1830090709 · Cited by 304
Self-citationWinchester, R. J., & Kunkel, H. G. (1980) · Advances in Immunology · doi:10.1016/s0065-2776(08)60801-9 · Cited by 270
Immunological dissection of human Ia molecules.
Tosi, R., Tanigaki, N., Centis, D., Ferrara, G. B., & Pressman, D. (1978) · The Journal of experimental medicine · doi:10.1084/jem.148.6.1592 · Cited by 263
“alsoseemstobe representedinloweramount than A and B lociproducts( 27 ).”
Bruggen, P. V. D., Szikora, J., Boël, P., Wildmann, C., Somville, M., Sensi, M., & Boon, T. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240930 · Cited by 228
Neefjes, J. J., & Ploegh, H. L. (1988) · European Journal of Immunology · doi:10.1002/eji.1830180522 · Cited by 223
Arce‐Gomez, B., Jones, E. A., Barnstable, C. J., Solomon, E., & Bodmer, W. F. (1978) · Tissue Antigens · doi:10.1111/j.1399-0039.1978.tb01233.x · Cited by 221
Self-citationJeffery, K. J. M., Siddiqui, A. A., Bunce, M., Lloyd, A. L., Vine, A. M., Witkover, A. D., Izumo, S., Usuku, K., Welsh, K. I., Osame, M., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.12.7278 · Cited by 222
“The level of HLA-C expression on the cell surface is ;10% of the level of expression of HLA-A and -B (39), and the nonsynonymous nucleotide substitution rate in the peptide binding region of HLA-C has also been reported to be lower in HLA-C than in HLA-A or -B (40).”
MacDonald, K. S., Embree, J., Njenga, S., Nagelkerke, N. J. D., Ngatia, I., Mohammed, Z., Barber, B. H., Ndinya‐Achola, J., Bwayo, J., & Plummer, F. A. (1998) · The Journal of Infectious Diseases · doi:10.1086/514243 · Cited by 196
“The poor seroreactivity of the C locus gene products may be in part a reflection of its lower baseline expression on the surface of most cells compared with that of the A and B locus products [25, 26].”
ResultLow HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA.
McCutcheon, J. A., Gumperz, J., Smith, K. D., Lutz, C. T., & Parham, P. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.6.2085 · Cited by 177
“(13) reported in 1977 that HLA-C molecules are expressed at the cell surface at levels much lower than either HLA-A or -B.”
BackgroundMaternal KIR and fetal HLA-C: a fine balance
Chazara, O., Xiong, S., & Moffett, A. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0511227 · Cited by 168
Distinctive polymorphism at the HLA-C locus: implications for the expression of HLA-C.
Zemmour, J., & Parham, P. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.4.937 · Cited by 169
“heterogeneity in their carbohydrate moiety (8).”
Adams, T. E., Bodmer, J. G., & Bodmer, W. F. (1983) · PubMed · Cited by 159
Self-citationMartin, M. P., & Carrington, M. N. (2013) · Immunological Reviews · doi:10.1111/imr.12071 · Cited by 175
HLA/KIR Restraint of HIV: Surviving the Fittest
Bashirova, A. A., Thomas, R., & Carrington, M. N. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101332 · Cited by 149
“, appearance of HIV-specific antibodies in serum) can be estimated based on sequential negative and positive test dates polymorphism and its low level of cell surface expression compared with its HLA-A and -B counterparts (129).”
Peptide ligand-induced conformation and surface expression of the Ld class I MHC molecule
Lie, W., Myers, N. B., Gorka, J., Rubocki, R. J., Connolly, J. M., & Hansen, T. H. (1990) · Nature · doi:10.1038/344439a0 · Cited by 147
Relative Expression Levels of the HLA Class-I Proteins in Normal and HIV-Infected Cells
Apps, R., Meng, Z., Prete, G. Q. D., Lifson, J. D., Zhou, M., & Carrington, M. N. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1403234 · Cited by 156
“(19) imprecisely defined the magnitude by which HLA-A and HLA-B expression was estimated to exceed that of HLA-C, which could only be determined as “at least 10 times” because”
BackgroundThe Dual Role of HLA-C in Tolerance and Immunity at the Maternal-Fetal Interface
Papúchová, H., Meissner, T. B., Li, Q., Strominger, J. L., & Tilburgs, T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02730 · Cited by 155
Monoclonal Antibodies to HLA–DRw Determinants
Brodsky, F. M., Parham, P., & Bodmer, W. F. (1980) · Tissue Antigens · doi:10.1111/j.1399-0039.1980.tb00285.x · Cited by 132
Self-citationNeisig, A., Melief, C. J. M., & Neefjes, J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.171 · Cited by 122
Structural and regulatory diversity shape HLA-C protein expression levels
Kaur, G., Gras, S., Mobbs, J. I., Vivian, J. P., Cortés, A., Barber, T. R., Kuttikkatte, S. B., Jensen, L. T., Attfield, K. E., Dendrou, C. A., et al. (2017) · Nature Communications · doi:10.1038/ncomms15924 · Cited by 127
Lie, W., Myers, N. B., Connolly, J. M., Gorka, J., Lee, D. R., & Hansen, T. H. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.173.2.449 · Cited by 115
Turnover in humans of β2‐microglobulin: the constant chain of HLA‐antigens
Karlsson, F. A., GROTH, T., Sege, K., Wibell, L. B., & Peterson, P. A. (1980) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1980.tb00036.x · Cited by 112
Role of .beta.2-microglobulin in the intracellular processing of HLA antigens
Sege, K., Rask, L., & Peterson, P. A. (1981) · Biochemistry · doi:10.1021/bi00519a003 · Cited by 109
Single-Center Kidney Paired Donation: The Methodist San Antonio Experience
Bingaman, A. W., Wright, F. H., Kapturczak, M., Shen, L. Y., Vick, S., & Murphey, C. L. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04070.x · Cited by 107
“Antibodies to HLA C antigens were not assigned because of lower surface expression levels of C locus antigens (21,22).”
BackgroundTurnover in humans of β2-microglobulin: the constant chain of HLA-antigens
Karlsson, F. A., Groth, T., Sege, K., Wibell, L. B., & Peterson, P. A. (1971) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1971.tb00634.x · Cited by 105
Johnson, R. P., Piechocka‐Trocha, A., Buchanan, T. M., & Walker, B. D. (1993) · Journal of Virology · doi:10.1128/jvi.67.1.438-445.1993 · Cited by 105
“HLA-C molecules share a number of features with HLA-A and -B molecules, including sequence homology, a comparable degree of polymorphism, association with 2-microglobulin, and expression on the cell surface of lymphocytes (14, 21, 42, 43, 46).”
BackgroundGenetic interplay between HLA-C and MIR148A in HIV control and Crohn disease
Kulkarni, S., Qi, Y., O’hUigin, C., Pereyra, F., Ramsuran, V., McLaren, P., Fellay, J., Nelson, G., Chen, H., Liao, W., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312237110 · Cited by 102
“J Acquir Immune Defic Syndr 5(5):490–496.”
Immunogenetics of Spontaneous Control of HIV
Carrington, M. N., & Walker, B. D. (2010) · Annual Review of Medicine · doi:10.1146/annurev-med-062909-130018 · Cited by 105
“Relative to HLA-A and -B, properly folded HLA-C molecules are expressed at a low level on the cell surface (37, 38, 42-44), partly because of their poor assembly with β2 microglobulin (42, 44) and retention in the endoplasmic reticulum where they are degraded to some extent (43).”
BackgroundMoss, D. J., Wallace, L. E., Rickinson, A. B., & Epstein, M. A. (1981) · European Journal of Immunology · doi:10.1002/eji.1830110904 · Cited by 90
Immunological function of HLA-C antigens in HLA-Cw3 transgenic mice.
Dill, O., Kievits, F., Koch, S., Ivanyi, P., & Hämmerling, G. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.15.5664 · Cited by 88
LILRB2 Interaction with HLA Class I Correlates with Control of HIV-1 Infection
Bashirova, A. A., Martin-Gayo, E., Jones, D. C., Qi, Y., Apps, R., Gao, X., Burke, P. S., Taylor, C. J., Rogich, J., Wolinsky, S., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004196 · Cited by 80
“The combined ABC binding score was a sum of A, B and C scores, but for HLA-C, only 1/10 of the sum was incorporated into the final score since HLA-C is known to be expressed on the cell surface at roughly 1/10 the level of HLA-A and -B [23].”
BackgroundEngineering immune-evasive allogeneic cellular immunotherapies
Martin, K. E., Hammer, Q., Perica, K., Sadelain, M., & Malmberg, K. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01022-8 · Cited by 69
“The deletion of B2M inhibits the surface expression of not only the classical HLA class Ia molecules HLA-A, HLA-B and HLA-C but also the less polymorphic HLA class Ib molecules HLA-E, HLA-F and HLA-G.”
InfluentialThe emerging role of HLA-C in HIV-1 infection
Kulpa, D. A., & Collins, K. L. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03474.x · Cited by 66
Distinctive Features of the α1-Domain a Helix of HLA-C Heavy Chains Free of β2-Microglobulin
Setini, A., Beretta, A., Santis, C. D., Meneveri, R., Martayan, A., Mazzilli, M. C., Appella, E., Siccardi, A. G., Natali, P. G., & Giacomini, P. (1996) · Human Immunology · doi:10.1016/0198-8859(96)00011-0 · Cited by 64
Levine, J. E., & Yang, S. Y. (1994) · Tissue Antigens · doi:10.1111/j.1399-0039.1994.tb02376.x · Cited by 64
Taglauer, E. S., Waldorf, K. M. A., & Petroff, M. G. (2009) · The International Journal of Developmental Biology · doi:10.1387/ijdb.082800et · Cited by 61
“The reduced polymorphism as compared to other class Ia proteins and its low expression on the surface of cells have been hypothesized to explain a lack of threat of HLAC to allorecognition (Snary et al., 1977; Trundley and Moffett, 2004).”
Human DR (Ia-Like) Antigens: Biological and Molecular Profile
Ferrone, S., Allison, J. P., & PELLEGRINO, M. A. (1978) · Springer eBooks · doi:10.1007/978-1-4757-0779-3_8 · Cited by 59
Arakawa, A., Reeves, E., Vollmer, S., Arakawa, Y., He, M. L., Galinski, A., Stöhr, J., Dornmair, K., James, E., & Prinz, J. C. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100686 · Cited by 63
“Cell surface-expression of HLA-C molecules is very low compared to HLA-A and HLA-B molecules and requires IFN-γ or other proinflammatory signals for a substantial upregulation (51, 52).”
BackgroundMolecular diversity of the HLA‐C locus in unrelated marrow transplantation
Petersdorf, E. W., Stanley, J. F., Martin, P. J., & Hansen, J. A. (1994) · Tissue Antigens · doi:10.1111/j.1399-0039.1994.tb02364.x · Cited by 55
The molecular basis for reactivity of anti‐Cw1 and anti‐Cw3 alloantisera with HLA‐B46 haplotypes
Zemmour, J., Gumpert, J. E., Hlldebrand, W. H., Ward, F. E., Marsh, S. G. E., Williams, R. C., & Parham, P. (1992) · Tissue Antigens · doi:10.1111/j.1399-0039.1992.tb01943.x · Cited by 54
HLA—A Central Immunological Agency of Man
Amos, D. B., & Kostyu, D. D. (1980) · Springer eBooks · doi:10.1007/978-1-4615-8288-5_2 · Cited by 51
A reliable and efficient high resolution typing method for HLA‐C using sequence‐based typing
Vlies, S. A. V. D., Voorter, C. E. M., & van den Berg-Loonen, E. M. (1998) · Tissue Antigens · doi:10.1111/j.1399-0039.1998.tb03087.x · Cited by 50
The Molecular Origin and Consequences of Escape from miRNA Regulation by HLA-C Alleles
Ó’hUigín, C., Kulkarni, S., Xu, Y., Deng, Z., Kidd, J. R., Kídd, K. K., Gao, X., & Carrington, M. N. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.07.024 · Cited by 49
Functional versus structural matching: can the CTLp test be replaced by HLA allele typing?
Oudshoorn, M., Doxiadis, I. I. N., van den Berg-Loonen, P. M., Voorter, C. E. M., Verduyn, W., & Claas, F. H. J. (2002) · Human Immunology · doi:10.1016/s0198-8859(01)00384-6 · Cited by 48
The New Kid on the Block: HLA-C, a Key Regulator of Natural Killer Cells in Viral Immunity
Vollmers, S., Lobermeyer, A., & Körner, C. (2021) · Cells · doi:10.3390/cells10113108 · Cited by 52
Garamszegi, L. Z. (2014) · Malaria Journal · doi:10.1186/1475-2875-13-349 · Cited by 48
“This observation is in good agreement with previous studies, suggesting that HLA B could be under a higher selective pressure from pathogens [24,43,44].”
Corrah, T., Goonetilleke, N. P., Kopycinski, J. T., Deeks, S. G., Cohen, M. S., Borrow, P., McMichael, A. J., & Brackenridge, S. (2011) · Journal of Virology · doi:10.1128/jvi.02276-10 · Cited by 47
“less than those of HLA-A and -B proteins (50).”
BackgroundMobbs, J. I., Illing, P. T., Dudek, N. L., Brööks, A. G., Baker, D. G., Purcell, A. W., Rossjohn, J., & Vivian, J. P. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.806976 · Cited by 51
“This disparity is partly attributable to studies on T-cell recognition tending to focus on HLA-A and HLA-B that are expressed on the cell surface at 3–10-fold higher levels than HLA-C (23, 24).”
Johnson, K. L., Ovsyannikova, I. G., Mason, C. J., Bergen, H. R., & Poland, G. A. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.09.126 · Cited by 47
“There is also an unknown contribution of peptides from the HLA-C allele, although the density of HLA-C molecules on the surface of cells has been reported as being 6-fold less than that of the A and B alleles [37,38].”
BackgroundHill, A. B., Takiguchi, M., & McMichael, A. J. (1993) · Immunogenetics · doi:10.1007/bf00216831 · Cited by 50
“s ion (Snary et al. 1977), less ex tens ive p o l y m o r p h i s m , and”
BackgroundHLA class I allelic diversity and progression of fibrosis in patients with chronic hepatitis C
Patel, K., Norris, S., Lebeck, L. K., Feng, A. C., Clare, M., Pianko, S., Portmann, B. C., Blatt, L. M., Koziol, J. A., Conrad, A. J., et al. (2006) · Hepatology · doi:10.1002/hep.21040 · Cited by 47
HLA-B51 transgenic mice as recipients for production of polymorphic HLA-A, B-specific antibodies
Karaki, S., Kariyone, A., Kato, N., Kano, K., Iwakura, Y., & Takiguchi, M. (1993) · Immunogenetics · doi:10.1007/bf00216838 · Cited by 45
“The surface expression level of HLA-C antigens is lower than that of HLA-A and -B antigens (Sodoyer et al. 1984; Snary et al. 1977).”
BackgroundHyun, S.-J., Sohn, H.-J., Lee, H.-J., Lee, S.-D., Kim, S., Sohn, D.-H., Hong, C.-H., Choi, H., Cho, H.-I., & Kim, T.-G. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01591 · Cited by 41
Conformation of human leucocyte antigen‐C molecules at the surface of human trophoblast cells
Apps, R., Gardner, L., Hiby, S. E., Sharkey, A., & Moffett, A. (2008) · Immunology · doi:10.1111/j.1365-2567.2007.02789.x · Cited by 44
Falk, C. S., Steinle, A., & Schendel, D. J. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.4.1005 · Cited by 44
Hillen, N., Mester, G., Lemmel, C., Weinzierl, A. O., Müller, M., Wernet, D., Hennenlotter, J., Stenzl, A., Rammensee, H., & Stevanović, S. (2008) · European Journal of Immunology · doi:10.1002/eji.200838632 · Cited by 43
The Discovery of Biomarkers in Cancer Immunotherapy
George, A. P., Kuzel, T. M., Zhang, Y., & Zhang, B. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.03.015 · Cited by 45
“The possible mechanism for this may involve increased cell surface expression of HLA-B expression and greater binding affinity of HLA-B alleles to a diverse array of peptides [66,67].”
BackgroundTaxonomic hierarchy of HLA class I allele sequences
McKenzie, L. M., Pecon‐Slattery, J., Carrington, M. N., & O’Brien, S. (1999) · Genes and Immunity · doi:10.1038/sj.gene.6363648 · Cited by 41
Trägårdh, L., Rask, L., Wiman, K. G., Fohlman, J., & Peterson, P. A. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.2.1129 · Cited by 41
Vasilov, R. G., Hahn, A., Mölders, H., van Rood, J. J., Breuning, M. H., & Ploegh, H. L. (1983) · Immunogenetics · doi:10.1007/bf00372454 · Cited by 40
HLA-C revisited: Ten Years of Change
Falk, C. S., & Schendel, D. J. (1997) · Immunologic Research · doi:10.1007/bf02786363 · Cited by 40
Law, H., & Bodmer, W. F. (1978) · Tissue Antigens · doi:10.1111/j.1399-0039.1978.tb01333.x · Cited by 38
Self-citationHaplotype characterization of transcribed ovine major histocompatibility complex (MHC) class I genes
Miltiadou, D., Ballingall, K. T., Ellis, S. A., Russell, G. C., & McKeever, D. J. (2005) · Immunogenetics · doi:10.1007/s00251-005-0008-y · Cited by 37
“In humans, alleles of the HLA-C locus exhibit less polymorphism (Falk and Schendel 1997) and are expressed at significantly lower levels compared to HLA-A and HLA-B (Snary et al. 1977; McCutcheon et al. 1995).”
BackgroundPlatelets: New Understanding of Platelet Glycoproteins and Their Role in Disease
Bussel, J. B., Kunicki, T. J., & Michelson, A. D. (2000) · Hematology · doi:10.1182/asheducation.v2000.1.222.222 · Cited by 36
Expression of classical HLA class I molecules: regulation and clinical impacts
René, C., Lozano, C., & Eliaou, J. (2016) · HLA · doi:10.1111/tan.12787 · Cited by 44
“Indeed, the HLA-A promoter is methylated at several CpG sites depending on alleles whereas HLA-B and HLA-C promoters are in a demethylated configuration (34).”
BackgroundInfluentialRamifications of HLA class I polymorphism and population genetics for vaccine development
Dawson, D. V., Ozgur, M., Sari, K., Ghanayem, M., & Kostyu, D. D. (2000) · Genetic Epidemiology · doi:10.1002/1098-2272(200101)20:1<87::aid-gepi8>3.0.co;2-r · Cited by 35
Jiang, T., Su, C., Cheng, R., Pan, Y., Zhang, H., He, J., He, Y., Tang, R., Ren, S., & Zhou, C. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr.2020.03.03 · Cited by 36
“This could be explained because HLA-B is generally expressed at higher levels than HLA-A and HLA-C on the cell surface, and they bind to a greater diversity of peptides (36).”
BackgroundImmunity at maternal–fetal interface: KIR / HLA (Allo)recognition*
Alexandrova, M., Manchorova, D., & Dimova, T. (2022) · Immunological Reviews · doi:10.1111/imr.13087 · Cited by 35
Distinctive polymorphism of chicken B-FI (major histocompatibility complex class I) molecules
Ewald, S. J., & Livant, E. J. (2004) · Poultry Science · doi:10.1093/ps/83.4.600 · Cited by 38
“Cell surface expression of the HLA-C molecules is about one-tenth that of HLA-A and -B molecules (Snary et al., 1977).”
BackgroundAmino acid sequence of an immunoglobulin-like HLA antigen heavy chain domain.
Trägårdh, L., Rask, L., Wiman, K. G., Fohlman, J., & Peterson, P. A. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.11.5839 · Cited by 34
Host Genetics of HIV Acquisition and Viral Control
Shea, P. R., Shianna, K. V., Carrington, M. N., & Goldstein, D. B. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-052511-135400 · Cited by 36
“Indeed, the functional importance of HLA-C was largely ignored historically because of its limited polymorphism (57) and low cell-surface expression (58, 59), but the discovery of its ligand relationship with KIR revived its status as a mainstay of the innate immune response.”
BackgroundHLA-C and HIV-1: friends or foes?
Zipeto, D., & Beretta, A. (2012) · Retrovirology · doi:10.1186/1742-4690-9-39 · Cited by 37
“It is generally agreed that HLA-C is surface-expressed at levels much lower (sometimes said to be ten-fold lower) than HLA-A and HLA-B [7] despite similar levels of transcription and translation [8].”
BackgroundHeavy HLA-DR (Ia) antigen chain is controlled by the MHC region
Klareskog, L., Rask, L., Fohlman, J., & Peterson, P. A. (1978) · Nature · doi:10.1038/275762a0 · Cited by 33
Evolution of MHC class I genes in higher primates
Lienert-Weidenbach, K., & Parham, P. (1996) · Immunology and Cell Biology · doi:10.1038/icb.1996.62 · Cited by 32
HLA‐A and ‐B (but not ‐C, ‐Bw4, Bw6 or ‐DR antigens) are expressed on purified spermatozoa
Rodriguez‐Córdoba, S., & Arnaiz‐Villena, A. (1985) · Tissue Antigens · doi:10.1111/j.1399-0039.1985.tb00406.x · Cited by 29
Vasoya, D., Law, A. S., Motta, P., Yu, M., Muwonge, A., Cook, E. A. J., Li, X., Bryson, K. J., MacCallam, A., Sitt, T., et al. (2016) · Immunogenetics · doi:10.1007/s00251-016-0945-7 · Cited by 30
“In humans HLA-A and HLA-B alleles are expressed at approximately equivalent levels and at about ∼5 to 15× higher levels that HLA-C (Apps et al. 2015; Snary et al. 1977), and there is evidence that variation in levels of expression of alleles from these loci can have significant clinical implications–for example, highe…”
BackgroundInfluentialMolecular diversity of the HLA-C gene identified in a caucasian population
Williams, F., Meenagh, A., Patterson, C. C., & Middleton, D. (2002) · Human Immunology · doi:10.1016/s0198-8859(02)00408-1 · Cited by 28
May, N. A., Glosson, N. L., & Hudson, A. W. (2010) · Journal of Virology · doi:10.1128/jvi.01782-09 · Cited by 27
“This pattern likely reflects the absence of HLA-A and -B in these cells and the relatively poor expression of HLA-C on the cell surface (36, 40, 50).”
BackgroundResultHoneyborne, I., Codoñer, F. M., Leslie, A. J., Tudor‐Williams, G., Luzzi, G. A., Ndung’u, T., Walker, B. D., Goulder, P., & Prado, J. G. (2010) · Journal of Virology · doi:10.1128/jvi.01144-10 · Cited by 33
“sion of HLA-C on the cell surface (18, 36, 37).”
BackgroundRubocki, R. J., Lee, D. R., Lie, W. R., Myers, N. B., & Hansen, T. H. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.6.2043 · Cited by 26
A Systematic, Unbiased Mapping of CD8+ and CD4+ T Cell Epitopes in Yellow Fever Vaccinees
Stryhn, A., Kongsgaard, M., Rasmussen, M., Harndahl, M. N., Østerbye, T., Bassi, M. R., Thybo, S., Gabriel, M., Hansen, M. B., Nielsen, M., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01836 · Cited by 26
“HLA-C is less polymorphic and is known to be expressed at a lower level than HLA-A and -B (53-56); something that has been correlated with reduced cytotoxic T lymphocyte responses (57, 58).”
Backgroundvan der Meer, A., Allebes, W. A., Paardekooper, J., Ruiter, J., & Joosten, I. (2001) · Transplantation · doi:10.1097/00007890-200109150-00030 · Cited by 26
Velasteguí, E., Vera, E., Berghe, W. V., Muñoz, M. S., & Orellana‐Manzano, A. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1206034 · Cited by 27
“In the early 1990s, its function in the human major histocompatibility complex was not known, only that it was the member of HLA class I with the lowest level of expression in cells (Snary et al., 1977; Dill et al., 1988).”
BackgroundThe Structure and Evolution of the HLA‐Bw4 and Bw6 Antigens
Barnstable, C. J., Snary, D., Crumpton, M. J., & Bodmer, W. F. (1979) · Tissue Antigens · doi:10.1111/j.1399-0039.1979.tb00805.x · Cited by 25
Self-citationGermline-Encoded TCR-MHC Contacts Promote TCR V Gene Bias in Umbilical Cord Blood T Cell Repertoire
Gao, K., Chen, L., Zhang, Y., Zhao, Y., Wan, Z., Wu, J., Lin, L., Kuang, Y., Lu, J., Zhang, X., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02064 · Cited by 24
Dean, C. L., Krummey, S. M., Gebel, H. M., Bray, R. A., & Sullivan, H. C. (2020) · Human Immunology · doi:10.1016/j.humimm.2019.12.006 · Cited by 24
“Thus, we may not expect positive flow crossmatches in these cases due to the lower expression of C-locus antigens as compared to HLA-A, B and DR antigens [12].”
ResultTibensky, D., & Delovitch, T. L. (1990) · Immunogenetics · doi:10.1007/bf02114976 · Cited by 23
Standardisation of a procedure for quantifying surface antigens by indirect immunofluorescence
Smith, K. B., & Ellis, S. A. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(99)00087-3 · Cited by 22
Stability and Expression Levels of HLA-C on the Cell Membrane Modulate HIV-1 Infectivity
Parolini, F., Biswas, P., Serena, M., Sironi, F. M., Muraro, V., Guizzardi, E., Cazzoletti, L., Scupoli, M. T., Gibellini, D., Ugolotti, E., et al. (2017) · Journal of Virology · doi:10.1128/jvi.01711-17 · Cited by 22
“HLA-C expression on the cell membrane is lower than that of HLA-A and -B (3, 4).”
BackgroundDeng, Z., Wang, D., Xu, Y., Gao, S.-Q., Zhou, H., Yu, Q., & Yang, B. (2010) · Human Immunology · doi:10.1016/j.humimm.2010.03.001 · Cited by 22
“It had been speculated that HLA-C molecules re deteriorating or lack function [1,2].”
Background
Metadata
- Authors
- Snary, D., Barnstable, C. J., Bodmer, W. F., & Crumpton, M. J.
- Affiliations
- University of Oxford (GB)
- Corresponding author
- Crumpton, M.J.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 1977-08
- Volume
- 7
- Issue
- 8
- Pages
- 580-585
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2099618881
- Cited by
- 181
- References
- 27
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 5 · 2023: 3 · 2022: 5 · 2021: 8 · 2020: 10 · 2019: 8 · 2018: 3 · 2017: 6 · 2016: 4 · 2015: 2 · 2014: 2 · 2013: 8 · 2012: 6
- FWCI
- 4.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Keywords
- HLA-C, histocompatibility antigens, beta2-microglobulin, antigenic structure, sedimentation, antigen expression
- MeSH terms
- beta 2-Microglobulin, Cell Line, Cell Membrane, Chemistry, Glycoproteins, Histocompatibility Antigens, HLA Antigens, Humans, Lymphocytes, Molecular Conformation, Molecular Weight, Chemical Phenomena
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.